Core Laboratories NV (CLB) Analysts See $0.48 EPS

Loring Wolcott & Coolidge Fiduciary Advisors Llp decreased Core Laboratories (CLB) stake by 33.26% reported in 2017Q2 SEC filing. Icm Asset Management Inc acquired 76,800 shares as Lowe's Companies Inc. The Icm Asset Management Inc holds 153,770 shares with $11.92 million value, up from 76,970 last quarter. Lowe's Companies Inc. now has $65.31 billion valuation. The stock increased 0.19% or $0.15 on September 22, reaching $78.23.

About 7,967 shares traded. It has underperformed by 10.78% the S&P500.

Analysts expect Core Laboratories N.V. (NYSE:CLB) to report $0.48 EPS on October, 23 after the close.They anticipate $0.10 EPS change or 26.32% from last quarter's $0.38 EPS. CLB's profit will be $21.18M for 50.28 P/E if the $0.48 EPS becomes a reality.

Investors wait Core Laboratories N.V. (NYSE:CLB) to report on October, 23 after the close. its quarterly earnings Wall Street analysts expect $0.48 earnings per share, up $0.10 or 26.32 % from last year's $0.38 same quarter earnings. The stock declined 0.05% or $0.05 reaching $96.54 per share. About 642,628 shares traded or 19.18% up from the average. Core Laboratories N.V. (NYSE:CLB) has declined 5.82% since September 23, 2016 and is downtrending. It has underperformed by 22.52% the S&P500.

Since March 24, 2017, it had 0 insider buys, and 4 insider sales for $12.06 million activity. DAMRON RICKY D sold $1.41 million worth of Lowe's Companies, Inc. (NYSE:LOW) on Saturday, April 1. Shares for $3.66M were sold by PARKER MARK G on Thursday, June 1. The company had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. Therefore 48% are positive. CLB was included in 43 notes of analysts from August 24, 2015. The firm earned "Market Perform" rating on Thursday, April 13 by Raymond James. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the company's stock. On Thursday, August 6 the stock rating was maintained by Deutsche Bank with "Hold". On Monday, January 9 the stock rating was downgraded by JP Morgan to "Neutral". The rating was initiated by Stephens on Tuesday, April 5 with "Equal-Weight". The most recent short interest data show 21.01% of the company's stock are short sold. RBC Capital Markets maintained Core Laboratories N.V. (NYSE:CLB) rating on Thursday, January 28. (NYSE:LOW) has "Buy" rating given on Friday, August 14 by Longbow. The rating was maintained by Piper Jaffray with "Hold" on Wednesday, August 23.

Investors sentiment increased to 1.08 in Q2 2017.

According to Zacks brokerage recommendations, Core Laboratories N.V. (NYSE:CLB)'s Buy count is 2 and Strong Buy is 1 while the number of analysts recommending Sell and Strong Sell are 0 and 4, respectively. 30 funds opened positions while 39 raised stakes. 606.01 million shares or 2.56% less from 621.93 million shares in 2017Q1 were reported. Eagleclaw Capital Managment Limited Liability Company invested 4.04% of its portfolio in Nike Inc (NYSE:NKE). Geneva Advisors Lc holds 0.02% or 10,355 shares in its portfolio. Van Eck Associate Corporation owns 474,454 shares or 0.26% of their United States portfolio. Geode Cap Ltd Com owns 318,966 shares. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.01. Blackrock holds 0.25% of its portfolio in Lowe's Companies, Inc. The Rbf Capital Llc holds 20,000 shares with $1.18M value, down from 30,000 last quarter. Yorktown Mgmt Research has invested 0.09% in Lowe's Companies, Inc. Us Bancorp De has invested 0.33% in Nike Inc (NYSE:NKE). Biondo Investment Limited Liability Corp invested 1.03% of its portfolio in Lowe's Companies, Inc. It also upped Ishares Tr (EEM) stake by 20,000 shares and now owns 50,000 shares. Invesco holds 0.19% of its portfolio in Lowe's Companies, Inc. Gradient Investments Limited holds 0.01% or 1,200 shares.

Investors sentiment decreased to 0.81 in Q2 2017. Its down 0.57, from 1.38 in 2017Q1. It increased, as 34 investors sold Core Laboratories N.V. shares while 106 reduced holdings. 43 funds opened positions while 108 raised stakes. The California-based Snyder Cap Mngmt Lp has invested 0.2% in Core Laboratories N.V. (NYSE:CLB).

Shares of Core Laboratories N.V. Art Advsrs Ltd Liability Corporation holds 0.05% of its portfolio in Core Laboratories N.V. (NYSE:CLB) for 9,300 shares. Over the 52-week time span, the stock notched a high price of $125.83 and its minimum price was $86.55. Long Road Investment Counsel Ltd Liability invested in 0.6% or 8,010 shares. Morgan Stanley restated an "overweight" rating and issued a $130.00 price target (down from $150.00) on shares of Core Laboratories a research note on Wednesday, June 21st. The analyst recommendations from a month ago are 1 Buy, 1 Strong Buy, 0 Sell, 1 Hold and 4. Epoch Inv Ptnrs stated it has 0.13% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Commonwealth Equity Svcs reported 3,503 shares.

Shares of Core Laboratories N.V. Commonwealth National Bank Of Aus invested in 900 shares. Maverick Capital stated it has 0.03% in Wix.Com Ltd (NASDAQ:WIX). Moreover, Trillium Asset Management Ltd Liability has 0.06% invested in Core Laboratories N.V. (NYSE:CLB) for 10,446 shares. The firm's stock has a market capitalization of $4.22 bln. The Firm operates through three divisions: Reservoir Description, Production Enhancement and Reservoir Management.

Like this



23 September 2017
Andy Townsend predicts where Man United will finish this season
Mourinho's side finished in sixth place in the Premier League table last season but also won the Europa League and League Cup. The two Manchester clubs now sit atop the Premier League table, with 13 points apiece.

23 September 2017
Regions Financial Corp (NYSE:RF) Q2 2017 Sentiment Report
A month ago, they told us to expect earnings of US$0.13 per share while three months ago their EPS consensus estimate was US$0.13. Supplementing insider data with technical indicators can help an investor form a more complete view on the outlook for a stock.

23 September 2017
North Korea Could Be Causing Problems For South Korea's 2018 Olympics
North and South Korea remain technically at war after their 1950-53 conflict ended with a truce and not a peace treaty. Other winter sports powerhouses said they were monitoring developments but had no plans to miss the Olympics.

23 September 2017
I was struggling initially, admits Kuldeep Yadav
Pacer Cummins (1/34) and left-arm spinner Agar (1/54) also picked up a wicket each for Australia . I did not bowl well from one end and it was getting hard to grip the ball as it was getting wet.

23 September 2017
Rodgers says Premier League would be fantastic for Celtic
Celtic boss Brendan Rodgers has little interest in what comes after Celtic on his CV - it could even be Ballymena United. It would be absolutely wonderful , and then you would see the true, real size of a club like Celtic ".

23 September 2017
How world leaders reacted to Trump's United Nations speech
The nuclear deal was negotiated with Iran by the United States, Russia, China, Britain, Germany and France. In any event, the U.S. "There was no yelling and we didn't throw shoes at one another", he said.

23 September 2017
Richard C. Young Trims Stake in Brookfield Renewable Partners
The company sells its generation output primarily to public power authorities, load-serving utilities, and industrial users. Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) previously released its periodic earnings reports on early Fri, Aug 4th.

23 September 2017
China tells Japan not to abandon dialogue over North Korea
The New Zealand dollar was down 0.3 percent at $0.7284 on jitters ahead of a hotly-contested general election on Saturday. The dollar was down 0.42 percent at 111.99 yen, on pace to snap a five-day winning streak against the Japanese currency.

23 September 2017
Axa Sells 61446 Shares of Incyte Corporation (NASDAQ:INCY)
Following the completion of the sale, the insider now directly owns 20,754 shares of the company's stock, valued at $2,864,052. The biopharmaceutical company reported ($0.96) EPS for the quarter, beating analysts' consensus estimates of ($0.97) by $0.01.

23 September 2017
Illinois Tool Works Inc. (ITW) Position Boosted by Dupont Capital Management Corp
On average, equities analysts forecast that Illinois Tool Works will post $6.45 earnings per share for the current fiscal year. The company has a market capitalization of $50.85 billion, a price-to-earnings ratio of 23.91 and a beta of 1.11.